Service & Software
Global In Vivo Pharmacology Service Market Research Report 2026
- Mar 17, 26
- ID: 743119
- Pages: 131
- Figures: 133
- Views: 16
This report delivers a comprehensive overview of the global In Vivo Pharmacology Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding In Vivo Pharmacology Service. The In Vivo Pharmacology Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global In Vivo Pharmacology Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist In Vivo Pharmacology Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
NuChem Sciences Inc
Eurofins Discovery
Oncodesign Services
Jubilant Biosys
Pharmaron
Melior Discovery
NUVISAN GmbH
Porsolt
Sygnature Discovery
Aurigene Pharmaceutical Services Ltd
Reaction Biology
Addexbio
Paraza Pharma, Inc
Aragen Life Sciences Ltd
Dalriada
Biocytogen
Charles River Laboratories
Pharmacelsu
HitGen Inc
TCG Lifesciences
Segment by Type
Small Molecule Screening
Large Molecule Screening
Others
Segment by Application
Neurological Diseases
Cardiovascular and Metabolic Diseases
Skin Diseases
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for In Vivo Pharmacology Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global In Vivo Pharmacology Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist In Vivo Pharmacology Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
NuChem Sciences Inc
Eurofins Discovery
Oncodesign Services
Jubilant Biosys
Pharmaron
Melior Discovery
NUVISAN GmbH
Porsolt
Sygnature Discovery
Aurigene Pharmaceutical Services Ltd
Reaction Biology
Addexbio
Paraza Pharma, Inc
Aragen Life Sciences Ltd
Dalriada
Biocytogen
Charles River Laboratories
Pharmacelsu
HitGen Inc
TCG Lifesciences
Segment by Type
Small Molecule Screening
Large Molecule Screening
Others
Segment by Application
Neurological Diseases
Cardiovascular and Metabolic Diseases
Skin Diseases
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for In Vivo Pharmacology Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Pharmacology Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Small Molecule Screening
1.2.3 Large Molecule Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vivo Pharmacology Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurological Diseases
1.3.3 Cardiovascular and Metabolic Diseases
1.3.4 Skin Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Pharmacology Service Market Perspective (2021–2032)
2.2 Global In Vivo Pharmacology Service Growth Trends by Region
2.2.1 Global In Vivo Pharmacology Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 In Vivo Pharmacology Service Historic Market Size by Region (2021–2026)
2.2.3 In Vivo Pharmacology Service Forecasted Market Size by Region (2027–2032)
2.3 In Vivo Pharmacology Service Market Dynamics
2.3.1 In Vivo Pharmacology Service Industry Trends
2.3.2 In Vivo Pharmacology Service Market Drivers
2.3.3 In Vivo Pharmacology Service Market Challenges
2.3.4 In Vivo Pharmacology Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Pharmacology Service Players by Revenue
3.1.1 Global Top In Vivo Pharmacology Service Players by Revenue (2021–2026)
3.1.2 Global In Vivo Pharmacology Service Revenue Market Share by Players (2021–2026)
3.2 Global Top In Vivo Pharmacology Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by In Vivo Pharmacology Service Revenue
3.4 Global In Vivo Pharmacology Service Market Concentration Ratio
3.4.1 Global In Vivo Pharmacology Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Pharmacology Service Revenue in 2025
3.5 Global Key Players of In Vivo Pharmacology Service Head Offices and Areas Served
3.6 Global Key Players of In Vivo Pharmacology Service, Products and Applications
3.7 Global Key Players of In Vivo Pharmacology Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 In Vivo Pharmacology Service Breakdown Data by Type
4.1 Global In Vivo Pharmacology Service Historic Market Size by Type (2021–2026)
4.2 Global In Vivo Pharmacology Service Forecasted Market Size by Type (2027–2032)
5 In Vivo Pharmacology Service Breakdown Data by Application
5.1 Global In Vivo Pharmacology Service Historic Market Size by Application (2021–2026)
5.2 Global In Vivo Pharmacology Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America In Vivo Pharmacology Service Market Size (2021–2032)
6.2 North America In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America In Vivo Pharmacology Service Market Size by Country (2021–2026)
6.4 North America In Vivo Pharmacology Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Pharmacology Service Market Size (2021–2032)
7.2 Europe In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe In Vivo Pharmacology Service Market Size by Country (2021–2026)
7.4 Europe In Vivo Pharmacology Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Pharmacology Service Market Size (2021–2032)
8.2 Asia-Pacific In Vivo Pharmacology Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2021–2026)
8.4 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In Vivo Pharmacology Service Market Size (2021–2032)
9.2 Latin America In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America In Vivo Pharmacology Service Market Size by Country (2021–2026)
9.4 Latin America In Vivo Pharmacology Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Pharmacology Service Market Size (2021–2032)
10.2 Middle East & Africa In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021–2026)
10.4 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc In Vivo Pharmacology Service Introduction
11.1.4 NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Eurofins Discovery
11.2.1 Eurofins Discovery Company Details
11.2.2 Eurofins Discovery Business Overview
11.2.3 Eurofins Discovery In Vivo Pharmacology Service Introduction
11.2.4 Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.2.5 Eurofins Discovery Recent Development
11.3 Oncodesign Services
11.3.1 Oncodesign Services Company Details
11.3.2 Oncodesign Services Business Overview
11.3.3 Oncodesign Services In Vivo Pharmacology Service Introduction
11.3.4 Oncodesign Services Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.3.5 Oncodesign Services Recent Development
11.4 Jubilant Biosys
11.4.1 Jubilant Biosys Company Details
11.4.2 Jubilant Biosys Business Overview
11.4.3 Jubilant Biosys In Vivo Pharmacology Service Introduction
11.4.4 Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.4.5 Jubilant Biosys Recent Development
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vivo Pharmacology Service Introduction
11.5.4 Pharmaron Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.5.5 Pharmaron Recent Development
11.6 Melior Discovery
11.6.1 Melior Discovery Company Details
11.6.2 Melior Discovery Business Overview
11.6.3 Melior Discovery In Vivo Pharmacology Service Introduction
11.6.4 Melior Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.6.5 Melior Discovery Recent Development
11.7 NUVISAN GmbH
11.7.1 NUVISAN GmbH Company Details
11.7.2 NUVISAN GmbH Business Overview
11.7.3 NUVISAN GmbH In Vivo Pharmacology Service Introduction
11.7.4 NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.7.5 NUVISAN GmbH Recent Development
11.8 Porsolt
11.8.1 Porsolt Company Details
11.8.2 Porsolt Business Overview
11.8.3 Porsolt In Vivo Pharmacology Service Introduction
11.8.4 Porsolt Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.8.5 Porsolt Recent Development
11.9 Sygnature Discovery
11.9.1 Sygnature Discovery Company Details
11.9.2 Sygnature Discovery Business Overview
11.9.3 Sygnature Discovery In Vivo Pharmacology Service Introduction
11.9.4 Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.9.5 Sygnature Discovery Recent Development
11.10 Aurigene Pharmaceutical Services Ltd
11.10.1 Aurigene Pharmaceutical Services Ltd Company Details
11.10.2 Aurigene Pharmaceutical Services Ltd Business Overview
11.10.3 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Introduction
11.10.4 Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.10.5 Aurigene Pharmaceutical Services Ltd Recent Development
11.11 Reaction Biology
11.11.1 Reaction Biology Company Details
11.11.2 Reaction Biology Business Overview
11.11.3 Reaction Biology In Vivo Pharmacology Service Introduction
11.11.4 Reaction Biology Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.11.5 Reaction Biology Recent Development
11.12 Addexbio
11.12.1 Addexbio Company Details
11.12.2 Addexbio Business Overview
11.12.3 Addexbio In Vivo Pharmacology Service Introduction
11.12.4 Addexbio Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.12.5 Addexbio Recent Development
11.13 Paraza Pharma, Inc
11.13.1 Paraza Pharma, Inc Company Details
11.13.2 Paraza Pharma, Inc Business Overview
11.13.3 Paraza Pharma, Inc In Vivo Pharmacology Service Introduction
11.13.4 Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.13.5 Paraza Pharma, Inc Recent Development
11.14 Aragen Life Sciences Ltd
11.14.1 Aragen Life Sciences Ltd Company Details
11.14.2 Aragen Life Sciences Ltd Business Overview
11.14.3 Aragen Life Sciences Ltd In Vivo Pharmacology Service Introduction
11.14.4 Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.14.5 Aragen Life Sciences Ltd Recent Development
11.15 Dalriada
11.15.1 Dalriada Company Details
11.15.2 Dalriada Business Overview
11.15.3 Dalriada In Vivo Pharmacology Service Introduction
11.15.4 Dalriada Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.15.5 Dalriada Recent Development
11.16 Biocytogen
11.16.1 Biocytogen Company Details
11.16.2 Biocytogen Business Overview
11.16.3 Biocytogen In Vivo Pharmacology Service Introduction
11.16.4 Biocytogen Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.16.5 Biocytogen Recent Development
11.17 Charles River Laboratories
11.17.1 Charles River Laboratories Company Details
11.17.2 Charles River Laboratories Business Overview
11.17.3 Charles River Laboratories In Vivo Pharmacology Service Introduction
11.17.4 Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.17.5 Charles River Laboratories Recent Development
11.18 Pharmacelsu
11.18.1 Pharmacelsu Company Details
11.18.2 Pharmacelsu Business Overview
11.18.3 Pharmacelsu In Vivo Pharmacology Service Introduction
11.18.4 Pharmacelsu Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.18.5 Pharmacelsu Recent Development
11.19 HitGen Inc
11.19.1 HitGen Inc Company Details
11.19.2 HitGen Inc Business Overview
11.19.3 HitGen Inc In Vivo Pharmacology Service Introduction
11.19.4 HitGen Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.19.5 HitGen Inc Recent Development
11.20 TCG Lifesciences
11.20.1 TCG Lifesciences Company Details
11.20.2 TCG Lifesciences Business Overview
11.20.3 TCG Lifesciences In Vivo Pharmacology Service Introduction
11.20.4 TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.20.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo Pharmacology Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Small Molecule Screening
1.2.3 Large Molecule Screening
1.2.4 Others
1.3 Market by Application
1.3.1 Global In Vivo Pharmacology Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Neurological Diseases
1.3.3 Cardiovascular and Metabolic Diseases
1.3.4 Skin Diseases
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Pharmacology Service Market Perspective (2021–2032)
2.2 Global In Vivo Pharmacology Service Growth Trends by Region
2.2.1 Global In Vivo Pharmacology Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 In Vivo Pharmacology Service Historic Market Size by Region (2021–2026)
2.2.3 In Vivo Pharmacology Service Forecasted Market Size by Region (2027–2032)
2.3 In Vivo Pharmacology Service Market Dynamics
2.3.1 In Vivo Pharmacology Service Industry Trends
2.3.2 In Vivo Pharmacology Service Market Drivers
2.3.3 In Vivo Pharmacology Service Market Challenges
2.3.4 In Vivo Pharmacology Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Pharmacology Service Players by Revenue
3.1.1 Global Top In Vivo Pharmacology Service Players by Revenue (2021–2026)
3.1.2 Global In Vivo Pharmacology Service Revenue Market Share by Players (2021–2026)
3.2 Global Top In Vivo Pharmacology Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by In Vivo Pharmacology Service Revenue
3.4 Global In Vivo Pharmacology Service Market Concentration Ratio
3.4.1 Global In Vivo Pharmacology Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo Pharmacology Service Revenue in 2025
3.5 Global Key Players of In Vivo Pharmacology Service Head Offices and Areas Served
3.6 Global Key Players of In Vivo Pharmacology Service, Products and Applications
3.7 Global Key Players of In Vivo Pharmacology Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 In Vivo Pharmacology Service Breakdown Data by Type
4.1 Global In Vivo Pharmacology Service Historic Market Size by Type (2021–2026)
4.2 Global In Vivo Pharmacology Service Forecasted Market Size by Type (2027–2032)
5 In Vivo Pharmacology Service Breakdown Data by Application
5.1 Global In Vivo Pharmacology Service Historic Market Size by Application (2021–2026)
5.2 Global In Vivo Pharmacology Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America In Vivo Pharmacology Service Market Size (2021–2032)
6.2 North America In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America In Vivo Pharmacology Service Market Size by Country (2021–2026)
6.4 North America In Vivo Pharmacology Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo Pharmacology Service Market Size (2021–2032)
7.2 Europe In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe In Vivo Pharmacology Service Market Size by Country (2021–2026)
7.4 Europe In Vivo Pharmacology Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In Vivo Pharmacology Service Market Size (2021–2032)
8.2 Asia-Pacific In Vivo Pharmacology Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2021–2026)
8.4 Asia-Pacific In Vivo Pharmacology Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In Vivo Pharmacology Service Market Size (2021–2032)
9.2 Latin America In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America In Vivo Pharmacology Service Market Size by Country (2021–2026)
9.4 Latin America In Vivo Pharmacology Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo Pharmacology Service Market Size (2021–2032)
10.2 Middle East & Africa In Vivo Pharmacology Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2021–2026)
10.4 Middle East & Africa In Vivo Pharmacology Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NuChem Sciences Inc
11.1.1 NuChem Sciences Inc Company Details
11.1.2 NuChem Sciences Inc Business Overview
11.1.3 NuChem Sciences Inc In Vivo Pharmacology Service Introduction
11.1.4 NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.1.5 NuChem Sciences Inc Recent Development
11.2 Eurofins Discovery
11.2.1 Eurofins Discovery Company Details
11.2.2 Eurofins Discovery Business Overview
11.2.3 Eurofins Discovery In Vivo Pharmacology Service Introduction
11.2.4 Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.2.5 Eurofins Discovery Recent Development
11.3 Oncodesign Services
11.3.1 Oncodesign Services Company Details
11.3.2 Oncodesign Services Business Overview
11.3.3 Oncodesign Services In Vivo Pharmacology Service Introduction
11.3.4 Oncodesign Services Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.3.5 Oncodesign Services Recent Development
11.4 Jubilant Biosys
11.4.1 Jubilant Biosys Company Details
11.4.2 Jubilant Biosys Business Overview
11.4.3 Jubilant Biosys In Vivo Pharmacology Service Introduction
11.4.4 Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.4.5 Jubilant Biosys Recent Development
11.5 Pharmaron
11.5.1 Pharmaron Company Details
11.5.2 Pharmaron Business Overview
11.5.3 Pharmaron In Vivo Pharmacology Service Introduction
11.5.4 Pharmaron Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.5.5 Pharmaron Recent Development
11.6 Melior Discovery
11.6.1 Melior Discovery Company Details
11.6.2 Melior Discovery Business Overview
11.6.3 Melior Discovery In Vivo Pharmacology Service Introduction
11.6.4 Melior Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.6.5 Melior Discovery Recent Development
11.7 NUVISAN GmbH
11.7.1 NUVISAN GmbH Company Details
11.7.2 NUVISAN GmbH Business Overview
11.7.3 NUVISAN GmbH In Vivo Pharmacology Service Introduction
11.7.4 NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.7.5 NUVISAN GmbH Recent Development
11.8 Porsolt
11.8.1 Porsolt Company Details
11.8.2 Porsolt Business Overview
11.8.3 Porsolt In Vivo Pharmacology Service Introduction
11.8.4 Porsolt Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.8.5 Porsolt Recent Development
11.9 Sygnature Discovery
11.9.1 Sygnature Discovery Company Details
11.9.2 Sygnature Discovery Business Overview
11.9.3 Sygnature Discovery In Vivo Pharmacology Service Introduction
11.9.4 Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.9.5 Sygnature Discovery Recent Development
11.10 Aurigene Pharmaceutical Services Ltd
11.10.1 Aurigene Pharmaceutical Services Ltd Company Details
11.10.2 Aurigene Pharmaceutical Services Ltd Business Overview
11.10.3 Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Introduction
11.10.4 Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.10.5 Aurigene Pharmaceutical Services Ltd Recent Development
11.11 Reaction Biology
11.11.1 Reaction Biology Company Details
11.11.2 Reaction Biology Business Overview
11.11.3 Reaction Biology In Vivo Pharmacology Service Introduction
11.11.4 Reaction Biology Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.11.5 Reaction Biology Recent Development
11.12 Addexbio
11.12.1 Addexbio Company Details
11.12.2 Addexbio Business Overview
11.12.3 Addexbio In Vivo Pharmacology Service Introduction
11.12.4 Addexbio Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.12.5 Addexbio Recent Development
11.13 Paraza Pharma, Inc
11.13.1 Paraza Pharma, Inc Company Details
11.13.2 Paraza Pharma, Inc Business Overview
11.13.3 Paraza Pharma, Inc In Vivo Pharmacology Service Introduction
11.13.4 Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.13.5 Paraza Pharma, Inc Recent Development
11.14 Aragen Life Sciences Ltd
11.14.1 Aragen Life Sciences Ltd Company Details
11.14.2 Aragen Life Sciences Ltd Business Overview
11.14.3 Aragen Life Sciences Ltd In Vivo Pharmacology Service Introduction
11.14.4 Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.14.5 Aragen Life Sciences Ltd Recent Development
11.15 Dalriada
11.15.1 Dalriada Company Details
11.15.2 Dalriada Business Overview
11.15.3 Dalriada In Vivo Pharmacology Service Introduction
11.15.4 Dalriada Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.15.5 Dalriada Recent Development
11.16 Biocytogen
11.16.1 Biocytogen Company Details
11.16.2 Biocytogen Business Overview
11.16.3 Biocytogen In Vivo Pharmacology Service Introduction
11.16.4 Biocytogen Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.16.5 Biocytogen Recent Development
11.17 Charles River Laboratories
11.17.1 Charles River Laboratories Company Details
11.17.2 Charles River Laboratories Business Overview
11.17.3 Charles River Laboratories In Vivo Pharmacology Service Introduction
11.17.4 Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.17.5 Charles River Laboratories Recent Development
11.18 Pharmacelsu
11.18.1 Pharmacelsu Company Details
11.18.2 Pharmacelsu Business Overview
11.18.3 Pharmacelsu In Vivo Pharmacology Service Introduction
11.18.4 Pharmacelsu Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.18.5 Pharmacelsu Recent Development
11.19 HitGen Inc
11.19.1 HitGen Inc Company Details
11.19.2 HitGen Inc Business Overview
11.19.3 HitGen Inc In Vivo Pharmacology Service Introduction
11.19.4 HitGen Inc Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.19.5 HitGen Inc Recent Development
11.20 TCG Lifesciences
11.20.1 TCG Lifesciences Company Details
11.20.2 TCG Lifesciences Business Overview
11.20.3 TCG Lifesciences In Vivo Pharmacology Service Introduction
11.20.4 TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (2021–2026)
11.20.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In Vivo Pharmacology Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Small Molecule Screening
Table 3. Key Players of Large Molecule Screening
Table 4. Key Players of Others
Table 5. Global In Vivo Pharmacology Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global In Vivo Pharmacology Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global In Vivo Pharmacology Service Market Size by Region (US$ Million), 2021–2026
Table 8. Global In Vivo Pharmacology Service Market Share by Region (2021–2026)
Table 9. Global In Vivo Pharmacology Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global In Vivo Pharmacology Service Market Share by Region (2027–2032)
Table 11. In Vivo Pharmacology Service Market Trends
Table 12. In Vivo Pharmacology Service Market Drivers
Table 13. In Vivo Pharmacology Service Market Challenges
Table 14. In Vivo Pharmacology Service Market Restraints
Table 15. Global In Vivo Pharmacology Service Revenue by Players (US$ Million), 2021–2026
Table 16. Global In Vivo Pharmacology Service Market Share by Players (2021–2026)
Table 17. Global Top In Vivo Pharmacology Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on In Vivo Pharmacology Service Revenue, 2025
Table 18. Ranking of Global Top In Vivo Pharmacology Service Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by In Vivo Pharmacology Service Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of In Vivo Pharmacology Service, Headquarters and Area Served
Table 21. Global Key Players of In Vivo Pharmacology Service, Products and Applications
Table 22. Global Key Players of In Vivo Pharmacology Service, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global In Vivo Pharmacology Service Market Size by Type (US$ Million), 2021–2026
Table 25. Global In Vivo Pharmacology Service Revenue Market Share by Type (2021–2026)
Table 26. Global In Vivo Pharmacology Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global In Vivo Pharmacology Service Revenue Market Share by Type (2027–2032)
Table 28. Global In Vivo Pharmacology Service Market Size by Application (US$ Million), 2021–2026
Table 29. Global In Vivo Pharmacology Service Revenue Market Share by Application (2021–2026)
Table 30. Global In Vivo Pharmacology Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global In Vivo Pharmacology Service Revenue Market Share by Application (2027–2032)
Table 32. North America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 34. North America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 35. Europe In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 37. Europe In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 47. NuChem Sciences Inc Company Details
Table 48. NuChem Sciences Inc Business Overview
Table 49. NuChem Sciences Inc In Vivo Pharmacology Service Product
Table 50. NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 51. NuChem Sciences Inc Recent Development
Table 52. Eurofins Discovery Company Details
Table 53. Eurofins Discovery Business Overview
Table 54. Eurofins Discovery In Vivo Pharmacology Service Product
Table 55. Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 56. Eurofins Discovery Recent Development
Table 57. Oncodesign Services Company Details
Table 58. Oncodesign Services Business Overview
Table 59. Oncodesign Services In Vivo Pharmacology Service Product
Table 60. Oncodesign Services Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 61. Oncodesign Services Recent Development
Table 62. Jubilant Biosys Company Details
Table 63. Jubilant Biosys Business Overview
Table 64. Jubilant Biosys In Vivo Pharmacology Service Product
Table 65. Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 66. Jubilant Biosys Recent Development
Table 67. Pharmaron Company Details
Table 68. Pharmaron Business Overview
Table 69. Pharmaron In Vivo Pharmacology Service Product
Table 70. Pharmaron Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 71. Pharmaron Recent Development
Table 72. Melior Discovery Company Details
Table 73. Melior Discovery Business Overview
Table 74. Melior Discovery In Vivo Pharmacology Service Product
Table 75. Melior Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 76. Melior Discovery Recent Development
Table 77. NUVISAN GmbH Company Details
Table 78. NUVISAN GmbH Business Overview
Table 79. NUVISAN GmbH In Vivo Pharmacology Service Product
Table 80. NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 81. NUVISAN GmbH Recent Development
Table 82. Porsolt Company Details
Table 83. Porsolt Business Overview
Table 84. Porsolt In Vivo Pharmacology Service Product
Table 85. Porsolt Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 86. Porsolt Recent Development
Table 87. Sygnature Discovery Company Details
Table 88. Sygnature Discovery Business Overview
Table 89. Sygnature Discovery In Vivo Pharmacology Service Product
Table 90. Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 91. Sygnature Discovery Recent Development
Table 92. Aurigene Pharmaceutical Services Ltd Company Details
Table 93. Aurigene Pharmaceutical Services Ltd Business Overview
Table 94. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product
Table 95. Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 96. Aurigene Pharmaceutical Services Ltd Recent Development
Table 97. Reaction Biology Company Details
Table 98. Reaction Biology Business Overview
Table 99. Reaction Biology In Vivo Pharmacology Service Product
Table 100. Reaction Biology Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 101. Reaction Biology Recent Development
Table 102. Addexbio Company Details
Table 103. Addexbio Business Overview
Table 104. Addexbio In Vivo Pharmacology Service Product
Table 105. Addexbio Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 106. Addexbio Recent Development
Table 107. Paraza Pharma, Inc Company Details
Table 108. Paraza Pharma, Inc Business Overview
Table 109. Paraza Pharma, Inc In Vivo Pharmacology Service Product
Table 110. Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 111. Paraza Pharma, Inc Recent Development
Table 112. Aragen Life Sciences Ltd Company Details
Table 113. Aragen Life Sciences Ltd Business Overview
Table 114. Aragen Life Sciences Ltd In Vivo Pharmacology Service Product
Table 115. Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 116. Aragen Life Sciences Ltd Recent Development
Table 117. Dalriada Company Details
Table 118. Dalriada Business Overview
Table 119. Dalriada In Vivo Pharmacology Service Product
Table 120. Dalriada Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 121. Dalriada Recent Development
Table 122. Biocytogen Company Details
Table 123. Biocytogen Business Overview
Table 124. Biocytogen In Vivo Pharmacology Service Product
Table 125. Biocytogen Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 126. Biocytogen Recent Development
Table 127. Charles River Laboratories Company Details
Table 128. Charles River Laboratories Business Overview
Table 129. Charles River Laboratories In Vivo Pharmacology Service Product
Table 130. Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 131. Charles River Laboratories Recent Development
Table 132. Pharmacelsu Company Details
Table 133. Pharmacelsu Business Overview
Table 134. Pharmacelsu In Vivo Pharmacology Service Product
Table 135. Pharmacelsu Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 136. Pharmacelsu Recent Development
Table 137. HitGen Inc Company Details
Table 138. HitGen Inc Business Overview
Table 139. HitGen Inc In Vivo Pharmacology Service Product
Table 140. HitGen Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 141. HitGen Inc Recent Development
Table 142. TCG Lifesciences Company Details
Table 143. TCG Lifesciences Business Overview
Table 144. TCG Lifesciences In Vivo Pharmacology Service Product
Table 145. TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 146. TCG Lifesciences Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. In Vivo Pharmacology Service Picture
Figure 2. Global In Vivo Pharmacology Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global In Vivo Pharmacology Service Market Share by Type: 2025 vs 2032
Figure 4. Small Molecule Screening Features
Figure 5. Large Molecule Screening Features
Figure 6. Others Features
Figure 7. Global In Vivo Pharmacology Service Market Size by Application (US$ Million), 2021–2032
Figure 8. Global In Vivo Pharmacology Service Market Share by Application: 2025 vs 2032
Figure 9. Neurological Diseases Case Studies
Figure 10. Cardiovascular and Metabolic Diseases Case Studies
Figure 11. Skin Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. In Vivo Pharmacology Service Report Years Considered
Figure 14. Global In Vivo Pharmacology Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global In Vivo Pharmacology Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global In Vivo Pharmacology Service Market Share by Region: 2025 vs 2032
Figure 17. Global In Vivo Pharmacology Service Market Share by Players in 2025
Figure 18. Global In Vivo Pharmacology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by In Vivo Pharmacology Service Revenue in 2025
Figure 20. North America In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 22. United States In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 26. Germany In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific In Vivo Pharmacology Service Market Share by Region (2021–2032)
Figure 34. China In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 42. Mexico In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 46. Israel In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. NuChem Sciences Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 50. Eurofins Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 51. Oncodesign Services Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 52. Jubilant Biosys Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 53. Pharmaron Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 54. Melior Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 55. NUVISAN GmbH Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 56. Porsolt Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 57. Sygnature Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 58. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 59. Reaction Biology Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 60. Addexbio Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 61. Paraza Pharma, Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 62. Aragen Life Sciences Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 63. Dalriada Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 64. Biocytogen Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 65. Charles River Laboratories Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 66. Pharmacelsu Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 67. HitGen Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 68. TCG Lifesciences Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Table 1. Global In Vivo Pharmacology Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Small Molecule Screening
Table 3. Key Players of Large Molecule Screening
Table 4. Key Players of Others
Table 5. Global In Vivo Pharmacology Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global In Vivo Pharmacology Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global In Vivo Pharmacology Service Market Size by Region (US$ Million), 2021–2026
Table 8. Global In Vivo Pharmacology Service Market Share by Region (2021–2026)
Table 9. Global In Vivo Pharmacology Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global In Vivo Pharmacology Service Market Share by Region (2027–2032)
Table 11. In Vivo Pharmacology Service Market Trends
Table 12. In Vivo Pharmacology Service Market Drivers
Table 13. In Vivo Pharmacology Service Market Challenges
Table 14. In Vivo Pharmacology Service Market Restraints
Table 15. Global In Vivo Pharmacology Service Revenue by Players (US$ Million), 2021–2026
Table 16. Global In Vivo Pharmacology Service Market Share by Players (2021–2026)
Table 17. Global Top In Vivo Pharmacology Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on In Vivo Pharmacology Service Revenue, 2025
Table 18. Ranking of Global Top In Vivo Pharmacology Service Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by In Vivo Pharmacology Service Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of In Vivo Pharmacology Service, Headquarters and Area Served
Table 21. Global Key Players of In Vivo Pharmacology Service, Products and Applications
Table 22. Global Key Players of In Vivo Pharmacology Service, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global In Vivo Pharmacology Service Market Size by Type (US$ Million), 2021–2026
Table 25. Global In Vivo Pharmacology Service Revenue Market Share by Type (2021–2026)
Table 26. Global In Vivo Pharmacology Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global In Vivo Pharmacology Service Revenue Market Share by Type (2027–2032)
Table 28. Global In Vivo Pharmacology Service Market Size by Application (US$ Million), 2021–2026
Table 29. Global In Vivo Pharmacology Service Revenue Market Share by Application (2021–2026)
Table 30. Global In Vivo Pharmacology Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global In Vivo Pharmacology Service Revenue Market Share by Application (2027–2032)
Table 32. North America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 34. North America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 35. Europe In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 37. Europe In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific In Vivo Pharmacology Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific In Vivo Pharmacology Service Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa In Vivo Pharmacology Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa In Vivo Pharmacology Service Market Size by Country (US$ Million), 2027–2032
Table 47. NuChem Sciences Inc Company Details
Table 48. NuChem Sciences Inc Business Overview
Table 49. NuChem Sciences Inc In Vivo Pharmacology Service Product
Table 50. NuChem Sciences Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 51. NuChem Sciences Inc Recent Development
Table 52. Eurofins Discovery Company Details
Table 53. Eurofins Discovery Business Overview
Table 54. Eurofins Discovery In Vivo Pharmacology Service Product
Table 55. Eurofins Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 56. Eurofins Discovery Recent Development
Table 57. Oncodesign Services Company Details
Table 58. Oncodesign Services Business Overview
Table 59. Oncodesign Services In Vivo Pharmacology Service Product
Table 60. Oncodesign Services Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 61. Oncodesign Services Recent Development
Table 62. Jubilant Biosys Company Details
Table 63. Jubilant Biosys Business Overview
Table 64. Jubilant Biosys In Vivo Pharmacology Service Product
Table 65. Jubilant Biosys Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 66. Jubilant Biosys Recent Development
Table 67. Pharmaron Company Details
Table 68. Pharmaron Business Overview
Table 69. Pharmaron In Vivo Pharmacology Service Product
Table 70. Pharmaron Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 71. Pharmaron Recent Development
Table 72. Melior Discovery Company Details
Table 73. Melior Discovery Business Overview
Table 74. Melior Discovery In Vivo Pharmacology Service Product
Table 75. Melior Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 76. Melior Discovery Recent Development
Table 77. NUVISAN GmbH Company Details
Table 78. NUVISAN GmbH Business Overview
Table 79. NUVISAN GmbH In Vivo Pharmacology Service Product
Table 80. NUVISAN GmbH Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 81. NUVISAN GmbH Recent Development
Table 82. Porsolt Company Details
Table 83. Porsolt Business Overview
Table 84. Porsolt In Vivo Pharmacology Service Product
Table 85. Porsolt Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 86. Porsolt Recent Development
Table 87. Sygnature Discovery Company Details
Table 88. Sygnature Discovery Business Overview
Table 89. Sygnature Discovery In Vivo Pharmacology Service Product
Table 90. Sygnature Discovery Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 91. Sygnature Discovery Recent Development
Table 92. Aurigene Pharmaceutical Services Ltd Company Details
Table 93. Aurigene Pharmaceutical Services Ltd Business Overview
Table 94. Aurigene Pharmaceutical Services Ltd In Vivo Pharmacology Service Product
Table 95. Aurigene Pharmaceutical Services Ltd Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 96. Aurigene Pharmaceutical Services Ltd Recent Development
Table 97. Reaction Biology Company Details
Table 98. Reaction Biology Business Overview
Table 99. Reaction Biology In Vivo Pharmacology Service Product
Table 100. Reaction Biology Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 101. Reaction Biology Recent Development
Table 102. Addexbio Company Details
Table 103. Addexbio Business Overview
Table 104. Addexbio In Vivo Pharmacology Service Product
Table 105. Addexbio Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 106. Addexbio Recent Development
Table 107. Paraza Pharma, Inc Company Details
Table 108. Paraza Pharma, Inc Business Overview
Table 109. Paraza Pharma, Inc In Vivo Pharmacology Service Product
Table 110. Paraza Pharma, Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 111. Paraza Pharma, Inc Recent Development
Table 112. Aragen Life Sciences Ltd Company Details
Table 113. Aragen Life Sciences Ltd Business Overview
Table 114. Aragen Life Sciences Ltd In Vivo Pharmacology Service Product
Table 115. Aragen Life Sciences Ltd Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 116. Aragen Life Sciences Ltd Recent Development
Table 117. Dalriada Company Details
Table 118. Dalriada Business Overview
Table 119. Dalriada In Vivo Pharmacology Service Product
Table 120. Dalriada Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 121. Dalriada Recent Development
Table 122. Biocytogen Company Details
Table 123. Biocytogen Business Overview
Table 124. Biocytogen In Vivo Pharmacology Service Product
Table 125. Biocytogen Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 126. Biocytogen Recent Development
Table 127. Charles River Laboratories Company Details
Table 128. Charles River Laboratories Business Overview
Table 129. Charles River Laboratories In Vivo Pharmacology Service Product
Table 130. Charles River Laboratories Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 131. Charles River Laboratories Recent Development
Table 132. Pharmacelsu Company Details
Table 133. Pharmacelsu Business Overview
Table 134. Pharmacelsu In Vivo Pharmacology Service Product
Table 135. Pharmacelsu Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 136. Pharmacelsu Recent Development
Table 137. HitGen Inc Company Details
Table 138. HitGen Inc Business Overview
Table 139. HitGen Inc In Vivo Pharmacology Service Product
Table 140. HitGen Inc Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 141. HitGen Inc Recent Development
Table 142. TCG Lifesciences Company Details
Table 143. TCG Lifesciences Business Overview
Table 144. TCG Lifesciences In Vivo Pharmacology Service Product
Table 145. TCG Lifesciences Revenue in In Vivo Pharmacology Service Business (US$ Million), 2021–2026
Table 146. TCG Lifesciences Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
Table 150. Authors List of This Report
List of Figures
Figure 1. In Vivo Pharmacology Service Picture
Figure 2. Global In Vivo Pharmacology Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global In Vivo Pharmacology Service Market Share by Type: 2025 vs 2032
Figure 4. Small Molecule Screening Features
Figure 5. Large Molecule Screening Features
Figure 6. Others Features
Figure 7. Global In Vivo Pharmacology Service Market Size by Application (US$ Million), 2021–2032
Figure 8. Global In Vivo Pharmacology Service Market Share by Application: 2025 vs 2032
Figure 9. Neurological Diseases Case Studies
Figure 10. Cardiovascular and Metabolic Diseases Case Studies
Figure 11. Skin Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. In Vivo Pharmacology Service Report Years Considered
Figure 14. Global In Vivo Pharmacology Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global In Vivo Pharmacology Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global In Vivo Pharmacology Service Market Share by Region: 2025 vs 2032
Figure 17. Global In Vivo Pharmacology Service Market Share by Players in 2025
Figure 18. Global In Vivo Pharmacology Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by In Vivo Pharmacology Service Revenue in 2025
Figure 20. North America In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 22. United States In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 26. Germany In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific In Vivo Pharmacology Service Market Share by Region (2021–2032)
Figure 34. China In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 42. Mexico In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa In Vivo Pharmacology Service Market Share by Country (2021–2032)
Figure 46. Israel In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE In Vivo Pharmacology Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. NuChem Sciences Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 50. Eurofins Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 51. Oncodesign Services Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 52. Jubilant Biosys Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 53. Pharmaron Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 54. Melior Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 55. NUVISAN GmbH Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 56. Porsolt Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 57. Sygnature Discovery Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 58. Aurigene Pharmaceutical Services Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 59. Reaction Biology Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 60. Addexbio Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 61. Paraza Pharma, Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 62. Aragen Life Sciences Ltd Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 63. Dalriada Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 64. Biocytogen Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 65. Charles River Laboratories Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 66. Pharmacelsu Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 67. HitGen Inc Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 68. TCG Lifesciences Revenue Growth Rate in In Vivo Pharmacology Service Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232